Sign in

CIK 0001631574

  • Large accelerated filer

Wave Life Sciences, Inc.

Sign in to watch
Ticker
WVE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-949-2900
Business address
733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
Former names
Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
  1. 4 Planned sale President and CEO sold 90,474 shares at $15.00 ($1,357,110)
  2. 4 Option exercise Chief Financial Officer acquired 25,000 shares (option exercise)
  3. 4 Open-market buy 10% owner bought 2,791,930 shares at $8.00 ($22,335,440)
  4. 4 Planned sale Chief Financial Officer sold 17,146 shares at $9.00 ($154,314)
  5. 4 Planned sale President and CEO sold 48,366 shares at $5.78 ($279,555)
  6. 4 Grant or award Director acquired 16,115 shares (grant or award)
  7. 4 Grant or award Director acquired 16,115 shares (grant or award)
  8. 4 Grant or award Director acquired 16,115 shares (grant or award)
  9. 4 Grant or award Director acquired 16,115 shares (grant or award)
  10. 4 Grant or award Director acquired 32,230 shares (grant or award)
  11. 4 Grant or award Director acquired 16,115 shares (grant or award)
  12. 4 Grant or award Director acquired 32,230 shares (grant or award)
  13. 4 Grant or award Director acquired 16,115 shares (grant or award)
  14. 4 Option exercise See Remarks acquired 68,210 shares (option exercise)
  15. 4 Planned sale Chief Financial Officer sold 15,630 shares at $6.17 ($96,421)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market buy 10% owner bought 3,300,000 shares at $5.00 ($16,500,000)

Page 4 of 14 · 274 filings